共查询到20条相似文献,搜索用时 46 毫秒
1.
Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats 总被引:7,自引:9,他引:7
Huntington's disease (HD) is caused by expansion of a glutamine repeat in
huntingtin. Mutant huntingtin contains 36-55 repeats in adult HD patients
and >60 repeats in juvenile HD patients. An N-terminal fragment of
mutant huntingtin forms aggregates in neuronal nuclei in the brains of
transgenic mice and HD patients. Aggregation of expanded polyglutamine is
thought to be a common pathological mechanism in HD and other glutamine
repeat diseases. It is not clear how the length of the repeats is
correlated with formation of protein aggregates. By expressing a series of
huntingtin constructs encoding various glutamine repeats (23-150 units) in
cultured cells we observed N-terminal fragments of huntingtin (amino acids
1-67 and 1-212), but not full- length huntingtins, with glutamine repeats
>/=66 units formed protein aggregates. Huntingtin aggregation was not
induced when the repeat was </=49 units and was markedly promoted by
very long repeats >/=120 units. This study suggests that various
N-terminal fragments of mutant huntingtin can form aggregates and that
aggregation is prompted by lengthening the glutamine repeat.
相似文献
2.
Schilling G; Becher MW; Sharp AH; Jinnah HA; Duan K; Kotzuk JA; Slunt HH; Ratovitski T; Cooper JK; Jenkins NA; Copeland NG; Price DL; Ross CA; Borchelt DR 《Human molecular genetics》1999,8(3):397-407
Huntington's disease (HD) is an inherited, neurodegenerative disorder
caused by the expansion of a glutamine repeat in the N-terminus of the
huntingtin protein. To gain insight into the pathogenesis of HD, we
generated transgenic mice that express a cDNA encoding an N-terminal
fragment (171 amino acids) of huntingtin with 82, 44 or 18 glutamines. Mice
expressing relatively low steady-state levels of N171 huntingtin with 82
glutamine repeats (N171-82Q) develop behavioral abnormalities, including
loss of coordination, tremors, hypokinesis and abnormal gait, before dying
prematurely. In mice exhibiting these abnormalities, diffuse nuclear
labeling, intranuclear inclusions and neuritic aggregates, all
immunoreactive with an antibody to the N-terminus (amino acids 1-17) of
huntingtin (AP194), were found in multiple populations of neurons. None of
these behavioral or pathological phenotypes were seen in mice expressing
N171-18Q. These findings are consistent with the idea that N-terminal
fragments of huntingtin with a repeat expansion are toxic to neurons, and
that N-terminal fragments are prone to form both intranuclear inclusions
and neuritic aggregates.
相似文献
3.
Characterization of neuron-specific huntingtin aggregates in human huntingtin knock-in mice 总被引:1,自引:0,他引:1
Sawada H Ishiguro H Nishii K Yamada K Tsuchida K Takahashi H Goto J Kanazawa I Nagatsu T 《Neuroscience research》2007,57(4):559-573
Huntington's disease (HD) is caused by a mutation causing expanded polyglutamine tracts in the N-terminal fragment of huntingtin. A pathological hallmark of HD is the formation of aggregates in the striatal neurons. Here we report that ageing human huntingtin knock-in mice expressing mutant human huntingtin contained neuronal huntingtin aggregates, as revealed by immunohistochemical analysis. In heterozygous knock-in mice with 77 CAG repeats, aggregates of N-terminal fragments of huntingtin were specifically formed in nuclei and neuropils in the striatal projection neurons, and in neuropils in their projection regions. This aggregate formation progressed depending on age, became interacted with proteolytic or chaperone proteins, and occurred most prominently in the nucleus accumbens. These mutant mice demonstrated abnormal aggressive behavior. In homozygous knock-in mice, heavy deposits of intranuclear and neuropil aggregates were detected, which extended to other regions; and characteristic large perikaryal aggregates were also found in the affected neurons. However, cell death was not observed among the striatal and affected neurons of these mutant mice. Our results indicate that the polyglutamine aggregates do not necessarily correlate with neuronal death. These human huntingtin knock-in mice should be useful to provide an effective therapeutic approach against HD. 相似文献
4.
Expansion of a polyglutamine repeat in huntingtin causes Huntington's disease (HD). Although full-length huntingtin is predominantly distributed in the cytoplasm, N-terminal fragments of huntingtin with expanded polyglutamine tracts are able to accumulate in the nucleus and kill neurons through apoptotic pathways. Transgenic mice expressing N-terminal mutant huntingtin show intranuclear huntingtin accumulation and develop progressive neurological symptoms. Inhibiting caspase-1 can prolong the survival of these HD mice. How intranuclear huntingtin is associated with caspase activation and apoptosis is unclear. Here we report that intranuclear huntingtin induces the activation of caspase-3 and the release of cytochrome c from mitochondria in cultured cells. As a result, cells expressing intranuclear huntingtin undergo apoptosis. We show that intranuclear huntingtin increases the expression of caspase-1, which may in turn activate caspase-3 and trigger apoptosis. We propose that the increased level of caspase-1 induced by intranuclear huntingtin contributes to HD-associated cell death. 相似文献
5.
Expansion of CAG repeats within the coding region of target genes is the cause of several autosomal dominant neurodegenerative diseases including Huntington's disease (HD). A hallmark of HD is the proteolytic production of N-terminal fragments of huntingtin containing polyglutamine repeats that form ubiquitinated aggregates in the nucleus and cytoplasm of the affected neurons. In this study, we used an ecdysone-inducible stable mouse neuro2a cell line that expresses truncated N-terminal huntingtin (tNhtt) with different polyglutamine length, along with mice transgenic for HD exon 1, to demonstrate that the ubiquitin-proteasome pathway is involved in the pathogenesis of HD. Proteasomal 20S core catalytic component was redistributed to the polyglutamine aggregates in both the cellular and transgenic mouse models. Proteasome inhibitor dramatically increased the rate of aggregate formation caused by tNhtt protein with 60 glutamine (60Q) repeats, but had very little influence on aggregate formation by tNhtt protein with 150Q repeats. Both normal and polyglutamine-expanded tNhtt proteins were degraded by proteasome, but the rate of degradation was inversely proportional to the repeat length. The shift of the proteasomal components from the total cellular environment to the aggregates, as well as the comparatively slower degradation of tNhtt with longer polyglutamine, decreased the proteasome's availability for degrading other key target proteins, such as p53. This altered proteasomal function was associated with disrupted mitochondrial membrane potential, released cytochrome c from mitochondria into the cytosol and activated caspase-9- and caspase-3-like proteases. These results suggest that the impaired proteasomal function plays an important role in polyglutamine protein-induced cell death. 相似文献
6.
Huntington's disease (HD) is an autosomal dominant inheritable neurodegenerative disorder caused by expansion of a polyglutamine repeat in the amino-terminal region of huntingtin. Polyglutamine expansion causes mutant huntingtin to aggregate and accumulate in the nuclei and cytoplasm of neurons. The aggregated amino-terminal fragments of mutant huntingtin are toxic to neuronal cells and may be involved in the neurodegeneration in HD patient brains. Although nuclear mutant huntingtin has been found to affect gene expression, the effect of cytoplasmic mutant huntingtin remains to be investigated. We established stably transfected mouse neuroblastoma (N2a) cells that express soluble amino-terminal fragments of huntingtin containing 20 (20Q) or 150 (150Q) glutamine repeats. In these stable cell lines, both 20Q and 150Q are diffusely distributed in the cytoplasm without aggregate formation. However, the stable 150Q cells are deficient in neurite outgrowth. Compared with wild-type N2a cells and cells stably expressing 20Q, stable 150Q cells also have decreased viability and are more susceptible to apoptotic stimulation. These findings suggest that the cytoplasmic soluble mutant huntingtin is also toxic to cells. 相似文献
7.
Huntington's disease (HD) arises from an expanded polyglutamine (polyQ) in the N-terminus of the huntingtin (htt) protein. Neuronal degeneration and inclusions containing N-terminal fragments of mutant htt are present in the cortex and striatum of HD brain. Recently, a model of polyQ aggregate structure has been proposed on the basis of studies with synthetic polyQ peptides and includes an alternating beta-strand/beta-turn structure with seven glutamine residues per beta-strand. We tested this model in the context of the htt exon-1 N-terminal fragment in both mammalian cell culture and cultured primary cortical neurons. We found our data support this model in the htt protein and provide a better understanding of the structural basis of polyQ aggregation in toxicity in HD. 相似文献
8.
胞浆内非聚集型突变亨廷顿蛋白影响神经细胞的分化 总被引:1,自引:0,他引:1
目的:探讨胞浆内非聚集型突变亨廷顿蛋白(huntingtin,Htt)对神经细胞分化的影响。方法:利用磷酸钙沉淀法在培养的小鼠成神经瘤细胞(N2a细胞)瞬时或稳定转染编码正常或突变Htt的氨基末端片段的d)NA,观察突变Htt对视黄酸(retinoic acid,RA)和无血清培养刺激N2a细胞突起生长的影响。结果:在瞬时转染的N2a细胞中,20Q的正常Htt氨基末端片段弥散分布在胞浆内,150Q的突变Htt氨基末端片段在多数细胞胞浆内形成聚集物。在稳定表达150Q的N2a细胞部分克隆中,150Q弥散分布在胞浆内。无论是含突变Htt聚集物的瞬时转染细胞还是仅在胞浆中表达非聚集型突变Htt的稳定转染细胞,其突起生长能力均较表达正常Htt的瞬时转染细胞和稳定转染细胞差。结论:胞浆内非聚集型突变Htt也能影响神经细胞的分化。 相似文献
9.
10.
Amyloid Formation by Mutant Huntingtin: Threshold,Progressivity and Recruitment of Normal Polyglutamine Proteins 总被引:15,自引:0,他引:15
Huang C. Chris Faber Peter W. Persichetti Francesca Mittal Vivek Vonsattel Jean-Paul MacDonald Marcy E. Gusella James F. 《Somatic Cell and Molecular Genetics》1998,24(4):217-233
Huntington's disease (HD) is caused by an expanded CAG trinucleotide repeat encoding a tract of consecutive glutamines near the amino terminus of huntingtin, a large protein of unknown function. It has been proposed that the expanded polyglutamine stretch confers a new property on huntingtin and thereby causes cell and region-specific neurodegeneration. Genotype-phenotype correlations predict that this novel property appears above a threshold length (approximately 38 glutamines), becomes progressively more evident with increasing polyglutamine length, is completely dominant over normal huntingtin and is not appreciably worsened by a double genetic dose in HD homozygotes. Recently, an amino terminal fragment of mutant huntingtin has been found to form self-initiated fibrillar aggregates in vitro. We have tested the capacity for aggregation to assess whether this property matches the criteria expected for a fundamental role in HD pathogenesis. We find that that in vitro aggregation displays a threshold and progressivity for polyglutamine length remarkably similar to the HD disease process. Moreover, the mutant huntingtin amino terminus is capable of recruiting into aggregates normal glutamine tract proteins, such as the amino terminal segments of both normal huntingtin and of TATA-binding protein (TBP). Our examination of in vivo aggregates from HD post-mortem brains indicates that they contain an amino terminal segment of huntingtin of between 179 and 595 residues. They also contain non-huntingtin protein, as evidenced by immunostaining for TBP. Interestingly, like the in vitro aggregates, aggregates from HD brain display Congo red staining with green birefringence characteristic of amyloid. Our data support the view that the expanded polyglutamine segment confers on huntingtin a new property that plays a determining role in HD pathogenesis and could be a target for treatment. Moreover, the new property might have its toxic consequences by interaction with one or more normal polyglutamine-containing proteins essential for the survival of target neurons. 相似文献
11.
The molecular biology of Huntington's disease 总被引:1,自引:0,他引:1
Ho LW Carmichael J Swartz J Wyttenbach A Rankin J Rubinsztein DC 《Psychological medicine》2001,31(1):3-14
BACKGROUND: Huntington's disease (HD) is a fatal neurodegenerative disorder with an autosomal dominant mode of inheritance. It leads to progressive dementia, psychiatric symptoms and an incapacitating choreiform movement disorder, culminating in premature death. HD is caused by an increased CAG repeat number in a gene coding for a protein with unknown function, called huntingtin. The trinucleotide CAG codes for the amino acid glutamine and the expanded CAG repeats are translated into a series of uninterrupted glutamine residues (a polyglutamine tract). METHODS: This review describes the epidemiology, clinical symptomatology, neuropathological features and genetics of HD. The main aim is to examine important findings from animal and cellular models and evaluate how they have enriched our understanding of the pathogenesis of HD and other diseases caused by expanded polyglutamine tracts. RESULTS: Selective death of striatal and cortical neurons occurs. It is likely that the HD mutation confers a deleterious gain of function on the protein. Neuronal intranuclear inclusions containing huntingtin and ubiquitin develop in patients and transgenic mouse models of HD. Other proposed mechanisms contributing to neuropathology include excitotoxicity, oxidative stress, impaired energy metabolism, abnormal protein interactions and apoptosis. CONCLUSIONS: Although many interesting findings have accumulated from studies of HD and other polyglutamine diseases, there remain many unresolved issues pertaining to the exact roles of intranuclear inclusions and protein aggregates, the mechanisms of selective neuronal death and delayed onset of illness. Further knowledge in these areas will inspire the development of novel therapeutic strategies. 相似文献
12.
In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease 总被引:7,自引:1,他引:6
A unifying feature of the CAG expansion diseases is the formation of
intracellular aggregates composed of the mutant polyglutamine-expanded
protein. Despite the presence of aggregates in affected patients, the
precise relationship between aggregates and disease pathogenesis is
unresolved. Results from in vivo and in vitro studies of mutant huntingtin
have lead to the hypothesis that nuclear localization of aggregates is
critical for the pathology of Huntington's disease (HD). We tested this
hypothesis using a 293T cell culture model system that compared the
frequency and toxicity of cytoplasmic and nuclear huntingtin aggregates. We
first assessed the mode of nuclear transport of N-terminal fragments of
huntingtin, and show that the predicted endogenous NLS is not functional,
providing data in support of passive nuclear transport. This result
suggests that proteolysis is a necessary step for nuclear entry of
huntingtin. Additionally, insertion of nuclear import or export sequences
into huntingtin fragments containing 548 or 151 amino acids was used to
reverse the normal localization of these proteins. Changing the subcellular
localization of the fragments did not influence their total aggregate
frequency. There were also no significant differences in toxicity
associated with the presence of nuclear compared with cytoplasmic
aggregates. The findings of nuclear and cytoplasmic aggregates in affected
brains, together with these in vitro data, support the nucleus and cytosol
as subcellular sites for pathogenesis in HD.
相似文献
13.
14.
Y. Narain A. Wyttenbach J. Rankin R. Furlong D. Rubinsztein 《Journal of medical genetics》1999,36(10):739-746
Huntington's disease (HD) is thought to show true dominance, since subjects with two mutant alleles have been reported to have similar ages at onset of disease compared to heterozygous sibs. We have investigated this phenomenon using a cell culture model. Protein aggregate formation was used as an indicator for pathology, as intraneuronal huntingtin inclusions are associated with pathology in vitro and in vivo. We showed that cytoplasmic and nuclear aggregates are formed by constructs comprising part of exon 1 of huntingtin with 41, 51, 66, or 72 CAG repeats, in a rate that correlates with repeat number. No inclusions were seen with 21 CAG repeat constructs. Mutant and wild type huntingtin fragments can be sequestered into inclusions seeded by a mutant huntingtin. Wild type huntingtin did not enhance or interfere with protein aggregation. The rate of protein aggregation was dose dependent for all mutant constructs tested. These experiments suggested a model for the dominance observed in HD; the decrease in the age at onset of a mutant homozygote may be small compared to the variance in the age at onset for that specific repeat number in heterozygotes. Our experiments also provide a model, which may explain the different repeat size ranges seen in patients and healthy controls for the different polyglutamine diseases. 相似文献
15.
16.
Huntington's disease (HD), is a genetic neurodegenerative disease characterized by a DNA CAG triplet repeat expansion in the first exon of the disease gene, HD. CAG DNA expansion results in a polyglutamine tract expansion in mutant huntingtin protein. Wild-type and mutant full-length huntingtin have been detected in the nucleus, but elevated levels of mutant huntingtin and huntingtin amino-terminal proteolytic fragments are seen to accumulate in the nuclei of HD-affected neurons. The presence of huntingtin in both the nucleus and the cytoplasm suggested that huntingtin may be dynamic between these compartments. By live cell time-lapse video microscopy, we have been able to visualize polyglutamine-mediated aggregation and the transient nuclear localization of huntingtin over time in a striatal cell line. A classical nuclear localization signal could not be detected in huntingtin, but we have discovered a nuclear export signal (NES) in the carboxy-terminus of huntingtin. Leptomycin B treatment of clonal striatal cells enhanced the nuclear localization of huntingtin, and a mutant NES huntingtin displayed increased nuclear localization, indicating that huntingtin can shuttle to and from the nucleus. The huntingtin NES is strictly conserved among all huntingtin proteins from diverse species. This export signal may be important in Huntington's disease because this fragment of huntingtin is proteolytically cleaved away during HD. The huntingtin NES therefore defines a potential role for huntingtin as a member of a nucleocytoplasmic dynamic protein complex. 相似文献
17.
Tebbenkamp AT Green C Xu G Denovan-Wright EM Rising AC Fromholt SE Brown HH Swing D Mandel RJ Tessarollo L Borchelt DR 《Human molecular genetics》2011,20(14):2770-2782
Recent studies have implicated an N-terminal caspase-6 cleavage product of mutant huntingtin (htt) as an important mediator of toxicity in Huntington's disease (HD). To directly assess the consequences of such fragments on neurologic function, we produced transgenic mice that express a caspase-6 length N-terminal fragment of mutant htt (N586) with both normal (23Q) and disease (82Q) length glutamine repeats. In contrast to mice expressing N586-23Q, mice expressing N586-82Q accumulate large cytoplasmic inclusion bodies that can be visualized with antibodies to epitopes throughout the N586 protein. However, biochemical analyses of aggregated mutant huntingtin in these mice demonstrated that the inclusion bodies are composed largely of a much smaller htt fragment (terminating before residue 115), with lesser amounts of full-length N586-82Q fragments. Mice expressing the N586-82Q fragment show symptoms typical of previously generated mice expressing mutant huntingtin fragments, including failure to maintain weight, small brain weight and reductions in specific mRNAs in the striatum. Uniquely, these N586-82Q mice develop a progressive movement disorder that includes dramatic deficits in motor performance on the rotarod and ataxia. Our findings suggest that caspase-6-derived fragments of mutant htt are capable of inducing novel HD-related phenotypes, but these fragments are not terminal cleavage products as they are subject to further proteolysis. In this scenario, mutant htt fragments derived from caspase 6, or possibly other proteases, could mediate HD pathogenesis via a 'hit and run' type of mechanism in which caspase-6, or other larger N-terminal fragments, mediate a neurotoxic process before being cleaved to a smaller fragment that accumulates pathologically. 相似文献
18.
Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice 总被引:3,自引:0,他引:3
Wheeler VC Gutekunst CA Vrbanac V Lebel LA Schilling G Hersch S Friedlander RM Gusella JF Vonsattel JP Borchelt DR MacDonald ME 《Human molecular genetics》2002,11(6):633-640
In Huntington's disease (HD), CAG repeats extend a glutamine tract in huntingtin to initiate the dominant loss of striatal neurons and chorea. Neuropathological changes include the formation of insoluble mutant N-terminal fragment, as nuclear/neuropil inclusions and filter-trap amyloid, which may either participate in the disease process or be a degradative by-product. In young Hdh knock-in mice, CAGs that expand the glutamine tract in mouse huntingtin to childhood-onset HD lengths lead to nuclear accumulation of full-length mutant huntingtin and later accumulation of insoluble fragment. Here we report late-onset neurodegeneration and gait deficits in older Hdh(Q111) knock-in mice, demonstrating that the nuclear phenotypes comprise early stages in a disease process that conforms to genetic and pathologic criteria determined in HD patients. Furthermore, using the early nuclear-accumulation phenotypes as surrogate markers, we show in genetic experiments that the disease process, initiated by full-length mutant protein, is hastened by co-expression of mutant fragment; therefore, accrual of insoluble-product in already compromised neurons may exacerbate pathogenesis. In contrast, timing of early disease events was not altered by normal huntingtin or by mutant caspase-1, two proteins shown to reduce inclusions and glutamine toxicity in other HD models. Thus, potential HD therapies in man might be directed at different levels: preventing the disease-initiating mechanism or slowing the subsequent progression of pathogenesis. 相似文献
19.
Sato A; Shimohata T; Koide R; Takano H; Sato T; Oyake M; Igarashi S; Tanaka K; Inuzuka T; Nawa H; Tsuji S 《Human molecular genetics》1999,8(6):997-1006
To investigate the molecular mechanisms of neurodegeneration caused by
expanded CAG repeats in dentatorubral-pallidoluysian atrophy (DRPLA), an
autosomal dominant neuro degrees enerative disorder caused by unstable
expansion of a CAG trinucleotide repeat in the DRPLA gene on 12p13.31, we
established an efficient expression system for truncated and full-length
DRPLA proteins with normal or expanded polyglutamine stretches in
neuronally differentiated PC12 cells and fibroblasts using an adenovirus
expression system. Although aggregate body formation was observed both in
neuronally differentiated PC12 cells and in fibroblasts expressing
truncated DRPLA proteins with Q82, >97% ( n = 3) of neuronally
differentiated PC12 cells showed intra-nuclear inclusions, while only 31
21% ( n = 3) of fibro-blasts had intranuclear inclusions at 3 days after
infection. The percentage of apoptotic cells was significantly higher in
neuronally differentiated PC12 cells expressing the truncated DRPLA protein
with Q82 than in fibroblasts, suggesting the possibility that intranuclear
aggregate bodies are formed preferentially in neuronally differentiated
PC12 cells and that these cells are more vulnerable than fibroblasts to the
toxic effects of expanded polyglutamine stretches in the DRPLA protein.
When the full- length DRPLA protein with Q82 was expressed, aggregate
bodies were found exclusively in the nuclei of the neuronally
differentiated PC12 cells, while they were found in the cytoplasm of
fibroblasts. Despite the presence of aggregate bodies, apoptosis was not
induced by expression of the full-length DRPLA protein with Q82 in either
neuronally differentiated PC12 cells or fibroblasts, suggesting that the
presence of intranuclear aggregate bodies is in itself not necessarily
toxic to cells.
相似文献
20.
Wheeler VC White JK Gutekunst CA Vrbanac V Weaver M Li XJ Li SH Yi H Vonsattel JP Gusella JF Hersch S Auerbach W Joyner AL MacDonald ME 《Human molecular genetics》2000,9(4):503-513
Huntington's disease (HD) is caused by an expanded N-terminal glutamine tract that endows huntingtin with a striatal-selective structural property ultimately toxic to medium spiny neurons. In precise genetic models of juvenile HD, HdhQ92 and HdhQ111 knock-in mice, long polyglutamine segments change huntingtin's physical properties, producing HD-like in vivo correlates in the striatum, including nuclear localization of a version of the full-length protein predominant in medium spiny neurons, and subsequent formation of N-terminal inclusions and insoluble aggregate. These changes show glutamine length dependence and dominant inheritance with recruitment of wild-type protein, critical features of the altered HD property that strongly implicate them in the HD disease process and that suggest alternative pathogenic scenarios: the effect of the glutamine tract may act by altering interaction with a critical cellular constituent or by depleting a form of huntingtin essential to medium spiny striatal neurons. 相似文献